SCHEMBL22504196

SCHEMBL22504196

CCCCOC(=O)c1c(C)noc1-c1ccc(Br)c(C)n1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.49
PKM P14618 2/20 0.49
KDM4E B2RXH2 2/20 0.49
POLB P06746 1/20 0.49
ESR1 P03372 4/20 0.40
HTT P42858 2/20 0.40
KCNH2 Q12809 1/20 0.40
HRH3 Q9Y5N1 1/20 0.40
L3MBTL1 Q9Y468 4/20 0.39
ATM Q13315 1/20 0.39
NPC1 O15118 1/20 0.39
TSHR P16473 5/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
LMNA P02545 2/20 0.39
CYP1A2 P05177 2/20 0.39
CYP2C19 P33261 2/20 0.39
MAPK1 P28482 2/20 0.39
CYP2D6 P10635 1/20 0.39
NR1H2 P55055 1/20 0.39
RNASEL Q05823 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25340410 0.82 HTT (0.59) ALDH1A1PKMKDM4EPOLBHTT
SCHEMBL29907964 0.82 HTT (0.59) ALDH1A1PKMKDM4EPOLBHTT
SCHEMBL22576482 0.79 ESR1 (0.52) ALDH1A1PKMKDM4EPOLBESR1
SCHEMBL22467593 0.79 HTT (0.43) ALDH1A1PKMKDM4EPOLBHTT
SCHEMBL29645214 0.79 HTT (0.43) ALDH1A1PKMKDM4EPOLBHTT
SCHEMBL21107996 0.78 POLB (0.41) ALDH1A1PKMKDM4EPOLBHTT
SCHEMBL29645215 0.78 POLB (0.41) ALDH1A1PKMKDM4EPOLBHTT
SCHEMBL24287859 0.76 ALDH1A1 (0.54) ALDH1A1PKMKDM4EPOLBHTT
SCHEMBL24287938 0.71 ALDH1A1 (0.59) ALDH1A1PKMKDM4EPOLBHTT
SCHEMBL30494008 0.71 ALDH1A1 (0.59) ALDH1A1PKMKDM4EPOLBHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11319309-B2 Cyclohexyl acid isoxazole azines as LPA antagonists BRISTOL-MYERS SQUIBB COMPANY (US) 2022-05-03 US disclosed
US-20200317656-A1 CYCLOHEXYL ACID ISOXAZOLE AZINES AS LPA ANTAGONISTS BRISTOL MYERS SQUIBB CO (US) 2020-10-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11319309-B2 Cyclohexyl acid isoxazole azines as LPA antagonists LPAR1, LPAR2, LPAR5 ALDH1A1 1903/4885PKM 2794/4885KDM4E 3787/4885
US-20200317656-A1 CYCLOHEXYL ACID ISOXAZOLE AZINES AS LPA ANTAGONISTS LPAR1, LPAR2, LPAR5 ALDH1A1 1903/4885PKM 2794/4885KDM4E 3787/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.